Hurlen, Mette <br/><br/>
Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis.  [electronic resource] 

 -  Thrombosis research  2006 
 - 433-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0049-3848 
<br/><br/><label>Standard No.: </label>10.1016/j.thromres.2005.07.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticoagulants--administration & dosage<br/>Aspirin--administration & dosage<br/>Drug Therapy, Combination<br/>Female<br/>Fibrinolytic Agents--administration & dosage<br/>Follow-Up Studies<br/>Hematuria--chemically induced<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Occult Blood<br/>Prospective Studies<br/>Risk Factors<br/>Treatment Outcome<br/>Warfarin--administration & dosage